ASH 2023 | Adoptive cellular therapy in AML: challenges and different approaches
Sankalp Arora
• 9 Dec 2023
Sankalp Arora, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of adoptive cellular therapies in acute myeloid leukemia (AML), with the primary focus being on overcoming the severe myeloablation and pancytopenia experienced by patients when targeting disease-specific antigens, which are expressed simultaneously on AML cells and healthy myeloid hematopoietic stem cells. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
